- Home
- HUMAW vs SENS Comparison
HUMAW vs SENS Comparison
Compare HUMAW & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUMAW | SENS |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | United States |
| Employees | 220 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 252.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HUMAW | SENS |
|---|---|---|
| Price | $0.10 | $6.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.58 |
| AVG Volume (30 Days) | 14.2K | ★ 373.2K |
| Earning Date | 03-21-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | N/A | $70.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 31.94 |
| 52 Week Low | $1.18 | $5.25 |
| 52 Week High | $1.34 | $28.00 |
Technical Indicators
Market Signals| Indicator | HUMAW | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 48.13 |
| Support Level | $0.08 | $6.03 |
| Resistance Level | $0.13 | $6.44 |
| Average True Range (ATR) | 0.03 | 0.35 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 26.29 | 17.91 |
Price Performance
Historical ComparisonAbout HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.